Literature DB >> 17560137

Expression of receptor activator of nuclear factor-kappaB ligand in synovial tissue: comparison with degradation of articular cartilage in temporomandibular joint disorders.

Keiseki Kaneyama1, Natsuki Segami, Jun Sato, Hiroshi Yoshimura, Rie Nishiura.   

Abstract

OBJECTIVE: The present study was performed to investigate the correlations between expression of the receptor activator of nuclear factor-kappaB ligand (RANKL) in synovial tissue and the degrees of synovitis, degeneration of articular cartilage, and adhesions in patients with internal derangement (ID) of the temporomandibular joint (TMJ). STUDY
DESIGN: Expression of RANKL, detected immunohistochemically, and the severity of arthroscopic features (synovitis, degenerative changes of articular eminence, and adhesion) in 30 patients with ID of the TMJ were assessed and the correlations between them were analyzed statistically.
RESULTS: RANKL expression was detected in the cytoplasm of synovial lining cells, endothelial cells, and fibroblast cells. However, there were no correlations between RANKL expression in any cell type and the severity of arthroscopic features.
CONCLUSION: These observations indicated that the cellular source of osteoclastic differentiation exists in TMJ with ID and may provide insight into the mechanism of osteoclast differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560137     DOI: 10.1016/j.tripleo.2007.02.016

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  2 in total

1.  Comparison of Serum and Salivary Antioxidants in Patients with Temporomandibular Joint Disorders and Healthy Subjects.

Authors:  Shirin Lawaf; Arash Azizi; Tohid Tabarestani
Journal:  J Dent (Tehran)       Date:  2015-04

Review 2.  Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms.

Authors:  Carla Alvarez; Gustavo Monasterio; Franco Cavalla; Luis A Córdova; Marcela Hernández; Dominique Heymann; Gustavo P Garlet; Timo Sorsa; Pirjo Pärnänen; Hsi-Ming Lee; Lorne M Golub; Rolando Vernal; Alpdogan Kantarci
Journal:  Front Immunol       Date:  2019-07-18       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.